AI-Powered Healthcare Stocks to Watch: Recursion Pharmaceuticals and [Other Company]

Recursion Pharmaceuticals uses AI to virtually test drugs and reduce the $900 million cost of bringing a drug to market. Its platform analyzes 50 petabytes of data to predict a drug's performance. The company partners with pharma giants like Sanofi and Roche to develop third-party prospects. Recursion Pharmaceuticals is still in its early stages, but expects significant revenue growth next fiscal year.